The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
23206862 |
22 |
Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an anti-obesity profile. |
Shionogi |
23025998 |
20 |
Identification of a novel and orally available benzimidazole derivative as an NPY Y5 receptor antagonist with in vivo efficacy. |
Shionogi |
22853998 |
164 |
Design, synthesis and identification of novel benzimidazole derivatives as highly potent NPY Y5 receptor antagonists with attractive in vitro ADME profiles. |
Shionogi |
22300657 |
29 |
Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist. |
Shionogi |
19596193 |
72 |
Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists. |
Tsukuba Research Institute |
19464889 |
43 |
Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists. |
Tsukuba Research Institute |
15951170 |
12 |
Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor. |
F. Hoffmann-La Roche |
15745805 |
13 |
Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design. |
F. Hoffmann-La Roche |
30399314 |
532 |
Design of Y |
TBA |
20030505 |
6 |
Stereoselective inhibition of butyrylcholinesterase by enantiomers of exo- and endo-2-norbornyl-N-n-butylcarbamates. |
Chung Shan Medical University Hospital |